secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001104659-23-045012
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech shareholders approve issuance of rights and Contingent Subsidiary Securities
--------------------------------------------------------------------------------

- Special meeting held April 10, 2023; quorum of 60,355,029 shares (53.2%).
- Proposal to satisfy Nasdaq Listing Rule 5635(c) approved: 50,498,193 for, 9,743,984 against, 112,852 abstentions.
- No broker non-votes on the issuance proposal.
- Approval allows issuance of rights and contingent securities in connection with prior financing arrangements.
- Vote was required under Nasdaq rules due to potential dilution exceeding 20% of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000110465923045012/0001104659-23-045012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000110465923045012/tm2312804d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-045012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer